Company: ADZCF
Filing Date: 2025-07-17
Form Type: 424B2
Source: 0000950103-25-008919
Chunk: 5

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-07-17
Form: 424B2
Chunk 5
---
 to the powers exercised by the competent resolution authority
to: (i) write down, including to zero, of any payment on the Notes; (ii) convert the Notes into ordinary shares of (a) the Issuer, (b)
any group entity or (c) any bridge bank or other instruments of ownership of such entities qualifying as common equity tier 1 capital
(and the issue to or conferral on the holders (including the beneficial owners) of such ordinary shares or instruments); and/or (iii)
apply any other resolution measure, including, but not limited to, any transfer of the Notes to another entity, the amendment, modification
or variation of the terms and conditions of the Notes or the cancellation of the Notes. The write-down and conversion powers are commonly
referred to as the “bail-in tool” and the bail-in tool and each of the other resolution measures are hereinafter referred
to as a “Resolution Measure.” By acquiring the Notes, you will be bound by and will be deemed irrevocably to consent
to the imposition of any Resolution Measure by the competent resolution authority as set forth in the accompanying prospectus dated April
26, 2024. Please read the risk factor “The Notes May Be Written Down, Be Converted into Ordinary Shares or Other Instruments of Ownership or Become Subject to Other Resolution Measures. You May Lose Some or All of Your Investment If Any Such Measure Becomes Applicable to Us” in this pricing supplement.

This is only a summary,
for more information please see the accompanying prospectus dated April 26, 2024, including the risk factors beginning on page 20 of such
prospectus.

<div align='center'>PS-3</div>

| Additional Information About the Issuer and the Notes |

You should read this pricing
supplement together with underlying supplement No. 1 dated April 26, 2024, product supplement C dated April 26, 2024, the prospectus supplement
dated April 26, 2024 relating to our Senior Debt Funding Notes, Series E of which these Notes are a part and the prospectus dated April
26, 2024. To the extent that disclosure in this pricing supplement is inconsistent with the disclosure in the underlying supplement, product
supplement, prospectus supplement or prospectus, the disclosure in this pricing supplement will control. You may access these documents
on the website of the Securities and Exchange Commission (the “SEC”) at.www.sec.gov
as follows (or, if